[ Price : $8.95]
Federal Register notice: FDA announces support for the most current B3-format annual version of the World Health Organization Drug...[ Price : $8.95]
Federal Register notice: FDA denies a request for a hearing and issues an order debarring Trang Doan Nguyen for five years from pr...[ Price : $8.95]
FDA approves an AstraZeneca NDA for Bydureon BCise (exenatide extended-release) injectable suspension, a new formulation designed ...[ Price : $8.95]
Federal Register notice: FDA determines that AstraZenecas Elavil (amitriptyline hydrochloride) oral tablets, 10 mg, 25 mg, 50 mg, ...[ Price : $8.95]
A new analysis from the RAND Corporation says biosimilar approvals should help cut healthcare spending by $54 billion over the nex...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes that the regulatory review period for Baxters Obizur is 4,21...[ Price : $8.95]
Federal Register notice: FDA makes available a new draft guidance for industry on generic methylphenidate hydrochloride oral exten...[ Price : $8.95]
FDA determines for patent extension purposes that the regulatory review period for Baxters Obizur is 4,216 days.